Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRFAP1 pseudogene 1 (MRFAP1P1), also annotated as HDRACA, is classified as a human pseudogene, lacking evidence of protein coding or direct biological activity. The nomenclature and alternative name HDRACA suggests a possible putative function ("high-density lipoprotein-regulated angiogenesis in coronary artery disease"), but there is no supporting data in authoritative gene or protein databases. Functional and disease-linked information found in literature pertains to the protein-coding gene MRFAP1, which affects protein-protein interaction networks in chromatin modification, cell cycle regulation, and possibly cancer. MRFAP1P1 itself is not a recognized therapeutic target nor is it associated with actionable molecular pathways[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRFAP1 pseudogene 1 (MRFAP1P1).